# Inflammatory Aspects of Glucose in Hyperlipidemia and Diabetes

> **NCT02130505** · NA · COMPLETED · sponsor: **Sint Franciscus Gasthuis** · enrollment: 51 (actual)

## Conditions studied

- Atherosclerosis
- Leukocyte Activation Disorder
- Type 2 Diabetes Mellitus
- Familial Combined Hyperlipidemia

## Interventions

- **DIETARY_SUPPLEMENT:** OGTT

## Key facts

- **NCT ID:** NCT02130505
- **Lead sponsor:** Sint Franciscus Gasthuis
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2014-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02130505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02130505, "Inflammatory Aspects of Glucose in Hyperlipidemia and Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02130505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*